The purpose of this study is to investigate the differences of gut Microbiome/Metabolite between ESRD patients and healthy subjects. Two hundred and twenty three hemodialysis patients and 70 healthy subjects are recruited, and a cross-sectional study is performed.
Study Type
OBSERVATIONAL
Enrollment
293
Beijing Anzhen Hospital
Beijing, China
General Hospital of Chinese Armed Police Forces
Beijing, China
Peking University Aerospace Centre Hospital
Beijing, China
Peking University Shougang Hospital
Beijing, China
Microbiota-derived uremic toxin
Time frame: Through study completion, an average of 1 year
Fecal Microbiome
Time frame: Through study completion, an average of 1 year
Fecal metabolites
Time frame: Through study completion, an average of 1 year
Blood metabolites
Time frame: Through study completion, an average of 1 year
Complete blood count
Time frame: Through study completion, an average of 1 year
Blood biochemistry test
Time frame: Through study completion, an average of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.